Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy

Letter in Response to the Article "Optimum Timing of Blood Tests for Monitoring Patients With Clostridium difficile-Associated Diarrhea" (J Investig Med.2010;58[4]:621-624)

(2016) Chaitanya Pant et al.   JOURNAL OF INVESTIGATIVE MEDICINE

A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies

(2013) Sapna R Parmar et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Epidemiology and Outcomes of Clostridium difficile Infections in Hematopoietic Stem Cell Transplant Recipients

(2012) C. D. Alonso et al.   CLINICAL INFECTIOUS DISEASES

Clostridium difficile Infection and Limitations of Markers for Severity in Patients with Hematologic Malignancy

(2012) Michael S. Wang et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Chemotherapy Patients with C. difficile Colitis Have Outcomes Similar to Immunocompetent C. difficile Patients

(2012) David B. Stewart et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Risk factors for mortality in Clostridium difficile infection in the general hospital population: a systematic review

(2012) M.G. Bloomfield et al.   JOURNAL OF HOSPITAL INFECTION

Risk factors associated withClostridium difficileinfection in adult oncology patients with a history of recent hospitalization for febrile neutropenia

(2012) Kenneth D. Bishop et al.   LEUKEMIA & LYMPHOMA

Fidaxomicin versus Vancomycin forClostridium difficileInfection

(2011) Thomas J. Louie et al.   NEW ENGLAND JOURNAL OF MEDICINE

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY

Infection Probability Score: A predictor of Clostridium difficile–associated disease onset in patients with haematological malignancy

(2010) Eleni Apostolopoulou et al.   European Journal of Oncology Nursing

Clostridium difficileinfection in cancer patients and hematopoietic stem cell transplant recipients

(2010) Teena Chopra et al.   Expert Review of Anti-Infective Therapy

Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

(2010) Stuart H. Cohen et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

A review of mortality due to Clostridium difficile infection

(2010) J.A. Karas et al.   JOURNAL OF INFECTION

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)

(2009) M.P. Bauer et al.   CLINICAL MICROBIOLOGY AND INFECTION

The Case for Vancomycin as the Preferred Drug for Treatment ofClostridium difficileInfection

(2008) John G. Bartlett   CLINICAL INFECTIOUS DISEASES

Rising Economic Impact of Clostridium difficile-Associated Disease in Adult Hospitalized Patient Population

(2008) Xiaoyan Song et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Risk factors for the development of fulminant Clostridium difficile colitis

(2008) Alexander J. Greenstein et al.   SURGERY